推荐产品
形狀
powder
包裝
pkg of 1 × 10 mg (880126P-10mg)
pkg of 1 × 100 mg (880126P-100mg)
pkg of 1 × 25 mg (880126P-25mg)
pkg of 1 × 50 mg (880126P-50mg)
pkg of 1 × 500 mg (880126P-500mg)
製造商/商標名
Avanti Research™ - A Croda Brand 880126P
運輸包裝
dry ice
儲存溫度
−20°C
SMILES 字串
[H][C@@](COP([O-])(OCCNC(OCCOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO/C=C\NC(CCN(C(C=C1)=O)C1=O)=O)=O)=O)(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C
應用
DSPE-PEG(2000)马来酰亚胺适合与光子敏感的细胞穿透肽(psCPP)共轭,制备纳米结构脂质载体。也适用通过非共价方式官能化氧化的多壁碳纳米管(O-MWCNs)。
生化/生理作用
DSPE-PEG(2000)马来酰亚胺用于制备共轭聚合物纳米粒子。适合用于合成官能化共轭物。
包裝
20 mL 透明玻璃螺旋盖小瓶 (880126P-500 mg)
5 mL琥珀色玻璃螺旋盖小瓶(880126P-100mg)
5 mL琥珀色玻璃螺旋盖小瓶(880126P-10mg)
5 mL琥珀色玻璃螺旋盖小瓶(880126P-25mg)
5 mL琥珀色玻璃螺旋盖小瓶(880126P-50mg)
法律資訊
Avanti Research is a trademark of Avanti Polar Lipids, LLC
儲存類別代碼
11 - Combustible Solids
其他客户在看
The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2
Biomaterials, 33(11), 3324-3333 (2012)
Conjugated Polymers for Biological and Biomedical Applications, 29-29 (2018)
EMBO molecular medicine, 11(12), e10923-e10923 (2019-11-12)
High extracellular matrix (ECM) content in solid cancers impairs tumour perfusion and thus access of imaging and therapeutic agents. We have devised a new approach to degrade tumour ECM, which improves uptake of circulating compounds. We target the immune-modulating cytokine
Journal of biomaterials science. Polymer edition, 31(3), 293-309 (2019-11-26)
This study aims to develop fluorescence labelled polymeric nanoparticle (NP) carrying vancomycin as the targeting agent for in vivo imaging of Methicillin-resistant Staphylococcus aureus bacterial infections in animal models. Maleimide functionalized 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide (polyethylene glycol)-2000] as the main was carrier matrix to
Drug delivery, 27(1), 502-518 (2020-04-02)
Reactive oxygen species (ROS)-induced neuronal mitochondrial dysfunction is a key pathologic factor in sporadic Alzheimer's disease (AD). Neuronal mitochondria have been proposed to be a promising therapeutic target for AD, especially for the failures of phase III clinical trials on
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门